- 1. SOD1
- [This gene plays a role in the detoxification of superoxide radicals in the cytosol. ( NCI )] (UMLS (NCI) C1420306) SOD1 Gene;
Superoxide Dismutase 1, Soluble (Amyotrophic Lateral Sclerosis 1 (Adult)) Gene =Gene or Genome | - 19. Sodium Phenylacetate
- (UMLS (NCI) C0142910) =Organic Chemical; Pharmacologic Substance ;
=phenylacetic acid;
Unclassified Ingredient Preparations =SODIUM PHENYLACETATE 10 % |
- 2. SOD2
- [This gene is involved in the detoxification of superoxide radicals produced within mitochondria. ( NCI )] (UMLS (NCI) C1420307) SOD2 Gene;
Superoxide Dismutase 2, Mitochondrial Gene =Gene or Genome | - 20. SODIUM PHOSPHATE
- [An inorganic compound used as a laxative, dietary supplement and for electrolyte-replacement purposes. Phosphate, a predominant intracellular anion, plays an important role in energy storage, osteoblastic and osteoclastic activities, regulating serum calcium concentrations, and numerous cellular phosphate-transfer reactions. Sodium phosphate increases fluidity of the intestinal contents by retention of water by osmotic forces, thereby indirectly inducing intestinal smooth muscle constriction. Sodium phosphate is also used in the renal excretion of hydrogen ions while promoting the reabsorption of sodium ions. ( NCI )] (UMLS (NCI) C0074757) =Pharmacologic Substance; Inorganic Chemical ;
=inorganic phosphate;
[TN408] PHOSPHORUS =SODIUM PHOSPHATE,TRIBASIC;
Sodium phosphate P32;
Sodium Phosphate Monobasic Monohydrate;
SODIUM BIPHOSPHATE;
SODIUM PHOSPHATE, DIBASIC;
SODIUM PHOSPHATE DIHYDRATE;
Sodium Phosphate, Dibasic, Anhydrous;
SODIUM PHOSPHATE,TRIBASIC;
Sodium Phosphate Monobasic Monohydrate;
SODIUM BIPHOSPHATE;
SODIUM PHOSPHATE, DIBASIC;
Sermorelin 0.05 MG Injectable Solution;
CONTACT LENS DAILY CLEANER;
Naphazoline 0.5 MG/ML / Phenylephrine 5 MG/ML / Pyrilamine 2 MG/ML Nasal Solution;
OPTIGENE EYE WASH;
SUSPENDING VEHICLE (SF) LIQUID,ORAL;
ULTRACAL TUBE-FEEDING LIQUID;
SODIUM PHOSPHATE DIHYDRATE;
Sodium Phosphate, Dibasic, Anhydrous;
SODIUM PHOSPHATE 180 MG/ML;
SODIUM PHOSPHATE 4 GM;
SODIUM PHOSPHATE 8.75 MG;
SODIUM PHOSPHATE 1.8 GM/10ML;
SODIUM PHOSPHATE 700 MG;
SODIUM PHOSPHATE 0.143 %;
SODIUM PHOSPHATE 7 GM |
- 3. Sodestrin
- (UMLS (NCI) C0701269) =Organic Chemical; Pharmacologic Substance; Hormone
| - 21. Sodium Phosphate Dibasic Heptahydrate
- (UMLS (NCI) C0724570) SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE;
=Pharmacologic Substance; Inorganic Chemical ;
|
- 4. SODIUM ACETATE, ANHYDROUS
- [The anhydrous, sodium salt form of acetic acid. Sodium acetate anhydrous disassociates in water to form sodium ions (Na+) and acetate ions. Sodium is the principal cation of the extracellular fluid and plays a large part in fluid and electrolyte replacement therapies. Sodium acetate anhydrous is used as an electrolyte replenisher in isosmotic solution for parenteral replacement of acute losses of extracellular fluid without disturbing normal electrolyte balance. ( NCI )] (UMLS (NCI) C0887700) SODIUM ACETATE,ANHYDROUS;
SODIUM ACETATE,ANHYDROUS PREPARATION;
=Organic Chemical; Pharmacologic Substance ;
=[TN404] SODIUM;
Acetic Acid, Sodium Salt =SODIUM ACETATE,ANHYDROUS 121 MG;
SODIUM ACETATE,ANHYDROUS 222 MG/100ML;
SODIUM ACETATE,ANHYDROUS 32.8 MG;
SODIUM ACETATE,ANHYDROUS 49.2 MG;
SODIUM ACETATE,ANHYDROUS 6.14 GM/100ML;
SODIUM ACETATE,ANHYDROUS 40 MEQ/ML;
| - 22. Sodium Phosphate Monobasic Monohydrate
- (UMLS (NCI) C0724635) SODIUM PHOSPHATE MONOBASIC,MONOHYDRATE;
SODIUM PHOSPHATE MONOBASIC,MONOHYDRATE PREPARATION;
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE;
SODIUM PHOSPHATE,MONOBASIC,MONOHYDRATE;
SODIUM PHOSPHATE,MONOBASIC,MONOHYDRATE PREPARATION =Pharmacologic Substance; Inorganic Chemical ;
=SODIUM PHOSPHATE;
Inactive Ingredient Preparations;
Unclassified Ingredient Preparations;
=CONTACT LENS CLEANING SOLN;
SODIUM PHOSPHATE MONOBASIC,MONOHYDRATE 1102 GM;
SODIUM PHOSPHATE MONOBASIC,MONOHYDRATE 142 MG/ML;
SODIUM PHOSPHATE,MONOBASIC,MONOHYDRATE 15 MG/100ML |
- 5. sodium acetylhomotaurine
- [ ] (UMLS (CSP) C0142786) =Organic Chemical; Pharmacologic Substance ;
| - 23. SODIUM PHOSPHATE, DIBASIC
- (UMLS (NCI) C0772024) SODIUM PHOSPHATE,DIBASIC;
SODIUM PHOSPHATE,DIBASIC PREPARATION =Pharmacologic Substance; Inorganic Chemical ;
=SODIUM PHOSPHATE;
=CONTACT LENS CLEANING SOLN;
fluticasone 0.5 MG/ML Topical Cream;
Interferon beta-1a 0.03 MG/ML Injectable Solution;
ENSURE PUDDING (BUTTERSCOTCH);
Naphazoline 0.5 MG/ML Nasal Solution;
xylometazoline 0.5 MG/ML Nasal Solution;
methylbenzethonium 1 MG/ML Topical Cream;
COMPLEAT MODIFIED LIQUID;
COMPLEAT MODIFIED LIQUID (CLOSED SYSTEM);
COMPLEAT REGULAR FORMULA LIQUID;
CONTACT LENS RINSE/NEUTRALIZER (OXYSEPT 2) SOLN,15ML;
pegademase bovine 250 u/ml intramuscular solution;
TYPHOID Vi POLYSACCHARIDE (TYPHIM Vi) VACCINE;
TYPHOID Vi POLYSACCHARIDE (TYPHIM Vi) VACCINE,SYRINGE,0.5ML;
ULTRA-KLENZ,WOUND CLEANSER;
COMPLEAT REGULAR LIQUID (CLOSED SYSTEM);
Sodium Phosphate, Dibasic 142 MG/ML;
Sodium Phosphate, Dibasic 852 MG;
Sodium Phosphate, Dibasic 0.994 MG/ML;
SODIUM PHOSPHATE,DIBASIC 0.0189 MG;
SODIUM PHOSPHATE,DIBASIC 0.47 GM/100ML;
SODIUM PHOSPHATE,DIBASIC 12 MG/100ML;
SODIUM PHOSPHATE,DIBASIC 14.2 MG;
SODIUM PHOSPHATE,DIBASIC 14.2 MG/100ML;
SODIUM PHOSPHATE,DIBASIC 180 MG/100ML;
SODIUM PHOSPHATE,DIBASIC 276 MG/ML;
SODIUM PHOSPHATE,DIBASIC 28.4 MG;
SODIUM PHOSPHATE,DIBASIC 6.32 MG;
SODIUM PHOSPHATE,DIBASIC 6.6 MG;
SODIUM PHOSPHATE,DIBASIC 350 MG;
SODIUM PHOSPHATE,DIBASIC 1.53 % |
- 6. SODIUM BENZOATE
- [The sodium salt of BENZOIC ACID. It is used as an antifungal preservative in pharmaceutical preparations and foods. It may also be used as a test for liver function. ( MSH )] (UMLS (NCI) C0142805) =Organic Chemical; Pharmacologic Substance ;
=benzoate;
[PH000] PHARMACEUTICAL AIDS / REAGENTS =MASSE EMOLLIENT CREAM;
MINERAL OIL 1.4GM/5ML EMULSION;
Chlorpheniramine 0.2 MG/ML / Dextromethorphan 1 MG/ML / Pseudoephedrine 3 MG/ML Oral Solution;
CARA-KLENZ,SKIN & WOUND CLEANSER;
CARRINGTON INCONTINENCE SKIN KIT;
MINERAL OIL 1.4GM/PHENOLPHTHALEIN 67MG/5ML EMULSION;
PHISODERM FOR BABY SOAP;
SODIUM BENZOATE POWDER (GM);
CARRINGTON DRESSING GEL SPRAY,TOP;
MULTIVITAMINS W/MINERALS SYRUP;
CARRINGTON GEL,TOP;
PH SKIN CLEANSER;
PHISODERM SOAP;
SODIUM BENZOATE 125 MG/ML;
SODIUM BENZOATE 0.05 %;
SODIUM BENZOATE 60 MG/30ML;
SODIUM BENZOATE 10 % | - 24. Sodium Phosphate, Dibasic, Anhydrous
- (UMLS (NCI) C0982396) SODIUM PHOSPHATE,DIBASIC,ANHYDROUS;
SODIUM PHOSPHATE,DIBASIC,ANHYDROUS PREPARATION =Pharmacologic Substance; Inorganic Chemical ;
=SODIUM PHOSPHATE;
=SODIUM PHOSPHATE,DIBASIC,ANHYDROUS 0.998 GM |
- 7. SODIUM BICARBONATE
- [monosodium salt of carbonic acid, NaHCO3; used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions. ( CSP )] (UMLS (NCI) C0074722) =Organic Chemical; Pharmacologic Substance ;
=[GA100] ANTACIDS;
[TN409] BICARBONATES;
[TN404] SODIUM;
Sodium Compounds =baking powder;
CONTACT LENS CLEANING SOLN;
EFFERDENT DENTURE CLEANER TAB,EFFERVSC;
GLYCERIN/PHENOL 0.3%/NA BICARB/NA BORATE MOUTHWASH;
GORDOMATIC CRYSTALS;
MASSENGILL DOUCHE LIQUID CONCENTRATE,VAG;
PEDI-BATH SALTS;
POTASSIUM BITARTRATE/SODIUM BICARBONATE SUPP,RTL;
SODIUM BICARBONATE PWDR;
PSYLLIUM SUGAR FREE INSTANT MIX PWDR;
SODIUM BICARBONATE 200 MG/ML;
SODIUM BICARBONATE 325 MG;
SODIUM BICARBONATE 40 MG/ML;
SODIUM BICARBONATE 42 MG/ML;
SODIUM BICARBONATE 0.46 GM;
SODIUM BICARBONATE 650 MG;
SODIUM BICARBONATE 75 MG/ML;
SODIUM BICARBONATE 84 MG/ML;
SODIUM BICARBONATE 360 MG;
SODIUM BICARBONATE 50 MG/ML;
MASSENGILL DISPOSABLE DOUCHE BAKING SODA,VAG;
SODIUM BICARBONATE 70 MG;
SODIUM BICARBONATE 140 MG;
SODIUM BICARBONATE 3.1 GM;
SODIUM BICARBONATE 6.74 GM;
SODIUM BICARBONATE 0.05;
SODIUM BICARBONATE 0.091 %;
SODIUM BICARBONATE 1.16 GM;
SODIUM BICARBONATE 1.68 GM;
SODIUM BICARBONATE 2 GM;
SODIUM BICARBONATE 259.2 MG;
SODIUM BICARBONATE 420 MG;
SODIUM BICARBONATE 84 MG;
SODIUM BICARBONATE 59 % | - 25. Sodium Phosphate, Monobasic, Anhydrous
- (UMLS (NCI) C1165377) =Organic Chemical; Pharmacologic Substance
|
- 8. sodium channel
- [cell membrane glycoproteins selective for sodium ions; fast sodium current is associated with the action potential in neural membranes. ( CSP )] (UMLS (CSP) C0037492) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Ion Channel;
| - 26. Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride
- (UMLS (HL7) C1550082) =Clinical Drug ;
=Additive/Preservative;
|
- 9. sodium channel blocker
- [A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity. ( MSH )] (UMLS (CSP) C0872271) =Pharmacologic Substance ;
| - 27. Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride
- [Sodium polyanethol sulfonate in saline. Anticomplementary and antiphagocytic properties. Used in blood culture collection. ( HL7V3.0 )] (UMLS (HL7) C1561484) =Intellectual Product =MaterialEntityAdditive;
|
- 10. Sodium Chromate
- [A yellowish, crystalline, inorganic compound that emits toxic chromium fumes upon heating. Sodium chromate is highly corrosive and is a strong oxidizing agent. This substance is used in wood preservatives, drilling muds, cutting oils, water treatment, textile dyeing processes, inks, paints, leather tanning and as a corrosion inhibitor. Sodium chromate primarily affects the respiratory tract causing ulcerations, shortness of breath, bronchitis, pneumonia and asthma but can also affect the gastrointestinal tract, liver, kidneys and immune system. This substance is a known human carcinogen and is associated with an increased risk of developing lung cancer and cancer of the sinonasal cavity. (NCI05) ( NCI )] (UMLS (NCI) C0074735) =Pharmacologic Substance; Inorganic Chemical ;
=Chromates;
Sodium Compounds =Chromic-51Cr Acid, Disodium Salt;
| - 28. Sodium Polystyrene
- [A potassium ion exchange resin composed of benzene-diethyl polymer with ethenyl-benzene, sulfonated, sodium salt. Administered as an oral suspension, sodium polystyrene sulfonate lowers serum potassium levels by exchanging its sodium ions for potassium ions. Acting primarily in the large intestine, this agent also exchanges its sodium ions for calcium and magnesium ions, resulting in a decrease in serum calcium and magnesium levels. (NCI04) ( NCI )] (UMLS (NCI) C0142915) =Organic Chemical; Pharmacologic Substance ;
=polystyrene sulfonic acid;
[AD400] ANTIDOTES, DETERRENTS,AND POISON CONTROL EXCHANGE RESINS =SODIUM POLYSTYRENE SULFONATE POWDER (GM);
SODIUM POLYSTYRENE SULFONATE 15 GM/60ML;
SODIUM POLYSTYRENE SULFONATE 30 GM/120ML;
SODIUM POLYSTYRENE SULFONATE 50 GM/200ML;
|
- 11. Sodium Citrate Anhydrous
- (UMLS (NCI) C0982388) SODIUM CITRATE, ANHYDROUS;
SODIUM CITRATE,ANHYDROUS;
SODIUM CITRATE,ANHYDROUS PREPARATION =Organic Chemical; Pharmacologic Substance =Albright's Solution;
Inactive Ingredient Preparations =SODIUM CITRATE,ANHYDROUS 46.7 %;
SODIUM CITRATE,ANHYDROUS 470 MG/ML | - 29. Sodium Stibogluconate
- [Pentavalent antimony (Sb) in differential complex formation with gluconic acid with established leishmanicidal use and potential antitumor activity. The Sb moiety of sodium stibogluconate (SSG) may inhibit protein tyrosine phophorylases (PTPases) by covalently modifying sulfhydryl groups in PTPase cysteine residues, resulting in specific inactivation of SH2 domain-containing tyrosine phosphatases-1 and -2 (SHP-1 and SHP-2), PTPases which negatively regulate interferon (IFN) signaling; enhancement of IFN-induced Stat1 tyrosine phosphorylation; and induction of cellular protein tyrosine phosphorylation. SSG in combination with IFN-alpha may synergize to overcome tumor cell resistance to IFN-alpha-mediated apoptosis. ( NCI )] (UMLS (NCI) C0030895) =Organic Chemical; Pharmacologic Substance ;
|
- 12. Sodium Dibunate
- (UMLS (NCI) C0771059) =Organic Chemical; Pharmacologic Substance
| - 30. Sodium Succinate
- (UMLS (NCI) C0142928) =Organic Chemical; Pharmacologic Substance ;
=succinate;
Inactive Ingredient Preparations;
Unclassified Ingredient Preparations;
|
- 13. Sodium Dichromate
- [An orange to red colored, crystalline, inorganic compound that emits toxic chromium fumes upon heating. Sodium dichromate is highly corrosive and is a strong oxidizing agent. This substance is mainly used to produce other chromium compounds, but is also used in drilling muds, in metal treatments, in wood preservatives, in the production of dyes and organic chemicals and as a corrosion inhibitor. Sodium dichromate primarily affects the respiratory system causing ulcerations, shortness of breath, bronchitis, pneumonia and asthma but can also affect the gastrointestinal tract, liver, kidneys and immune system. This substance is a known human carcinogen and is associated with an increased risk of developing lung cancer and cancer of the sinonasal cavity. (NCI05) ( NCI )] (UMLS (NCI) C0074724) =Hazardous or Poisonous Substance; Inorganic Chemical ;
| - 31. SODIUM SULFATE, ANHYDROUS
- [The anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions. ( NCI )] (UMLS (NCI) C0771797) =Pharmacologic Substance; Inorganic Chemical
|
- 14. Sodium Fluoride
- [Sodium fluoride ( HL7V3.0 )] (UMLS (HL7) C1556062) =Intellectual Product =MaterialEntityAdditive;
| - 32. Sodium Sulfite
- [A chemical used in photography, paper making, water treatment, and for other purposes. ( NCI )] (UMLS (NCI) C0074771) =Pharmacologic Substance; Inorganic Chemical ;
=sulfite;
Inactive Ingredient Preparations;
Unclassified Ingredient Preparations;
=Atropine 0.14 MG/ML / Edrophonium 10 MG/ML Injectable Solution;
Benzocaine / resorcinol Topical Cream;
SODIUM SULFITE 20 MG/100ML;
SODIUM SULFITE 0.0125 % |
- 15. Sodium Fluoride, 100mg
- (UMLS (HL7) C1550069) =Clinical Drug; ;
=Additive/Preservative;
| - 33. Sodium/Na EDTA
- (UMLS (HL7) C1550064) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =Additive/Preservative;
|
- 16. Sodium Fluoride, 100mg
- [Sodium fluoride, 100mg added as a urine preservative. ( HL7V3.0 )] (UMLS (HL7) C1561474) =Intellectual Product =MaterialEntityAdditive;
| - 34. Sodium/Na EDTA
- [Sodium fluoride and Disodium EDTA ( HL7V3.0 )] (UMLS (HL7) C1561468) =Intellectual Product =MaterialEntityAdditive;
|
- 17. Sodium Fluoride, 10mg
- [Sodium fluoride, 10mg added as a urine preservative. ( HL7V3.0 )] (UMLS (HL7) C1561473) =Intellectual Product =MaterialEntityAdditive;
| - 35. Sodium/Na Heparin
- [Sodium heparin salt ( HL7V3.0 )] (UMLS (HL7) C1550073) =Intellectual Product; ;
=MaterialEntityAdditive;
|
- 18. Sodium Monofluorophosphate
- (UMLS (NCI) C0142890) =Pharmacologic Substance; Inorganic Chemical ;
| |
home
